Bellerophon Therapeutics Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Drug Delivery
- Pulmonary
- Specialty Pharmaceuticals
- Vaccines
- Drug Delivery
- Digital Health
- Disease Management
Latest on Bellerophon Therapeutics Inc.
PTC Therapeutics, Inc. will receive $1bn as it expands a deal it did with Royalty Pharma plc in 2020 around royalties from the PTC/ Roche Holding AG -partnered spinal muscular atrophy drug Evrysdi
Since it has become difficult for many biopharmaceutical companies to raise money during the past year and a half, several firms have been forced to cut costs to make remaining cash balances last long
The failure of FibroGen, Inc. ’s Phase III MATTERHORN trial of roxadustat in anemia among patients with transfusion-dependent lower-risk myelodysplastic syndrome (MDS) likely seals the drug’s fate in
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Astellas Taps Selecta For Gene The